Renal haemangioblastoma: a clinicopathologic and molecular characterization of 8 cases supporting the presence of recurrent <scp>MTOR</scp> pathway alterations
This study contributes further understanding to the pathogenesis of renal haemangioblastoma and supports that it exists on a spectrum with RCC with haemangioblastoma-like features and RCC with FMS.
Authors
- Anjia Han (ORCID: https://orcid.org/0000-0003-3357-5348)
- Michelle S. Hirsch (ORCID: https://orcid.org/0000-0002-8767-8564)
- Stephanie Siegmund (ORCID: https://orcid.org/0000-0003-1848-2389)
- William J. Anderson (ORCID: https://orcid.org/0000-0002-5807-7831)
- Maria Del Carmen Rodriguez Peña (ORCID: https://orcid.org/0000-0002-3439-7013)
- Shujin He
Institutions
- Brigham and Women's Hospital (US)
- Harvard University (US)
- Sun Yat-sen University (CN)
- The First Affiliated Hospital, Sun Yat-sen University (CN)
Publication Details
- Journal
- Histopathology
- Published
- 2025-08-15
- DOI
- https://doi.org/10.1111/his.15538
- Citations
- 5
- Primary Topic
- Renal cell carcinoma treatment
- Type
- article
- Field-Weighted Citation Impact
- 7.59
Funders
- Brigham and Women's Hospital